Alseres Pharmaceuticals, Inc.

Chris Sterzinger

Richard M Thorn

Cara Ferreira

David Leyh

A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [I]-2&#x3b2;-carbomethoxy-3&#x3b2;-(4-flurophenyl)-N-(3-iodo-E-allyl) nortropane.

Labeled iodinated tropane formulation

A diagnostic formulation is provided comprising a tropane having a radioactive concentration of at least 1.6 mCi/mL at least about 51 hours post creation. The diagnostic formulation optionally comprises a radiolabeled dopamine transporter (DAT) ligand useful in the diagnosis of Parkinson's disease (PS). One example of a radiolabeled dopamine transporter (DAT) ligand example is [I]-2&#x3b2;-carbomethoxy-3&#x3b2;-(4-flurophenyl)-N-(3-iodo-E-allyl)nortropane.

Growing community of inventors

Vancouver, Canada

Chris Sterzinger